Special Anniversary Offer: Vanishing Tomorrow - Your Chance to Save 80%
Here is the latest financial fact sheet of VANTA BIOSCIENCE. For more details, see the VANTA BIOSCIENCE quarterly results and VANTA BIOSCIENCE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 5.0 |
No. of shares | m | 6.31 |
1 Week | % | 0.0 |
1 Month | % | -9.6 |
1 Year | % | 10.4 |
52 week H/L | Rs | 101.6/37.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
VANTA BIOSCIENCE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 153 | 195 | 196 | 190 | 138 | |
Low | Rs | 46 | 80 | 80 | 105 | 56 | |
Sales per share (Unadj.) | Rs | 18.6 | 21.2 | 15.2 | 15.4 | 9.9 | |
Earnings per share (Unadj.) | Rs | 1.1 | 1.6 | 0.7 | 0.2 | -16.6 | |
Diluted earnings per share | Rs | 1.1 | 1.6 | 0.7 | 0.2 | -16.5 | |
Cash flow per share (Unadj.) | Rs | 2.2 | 3.5 | 2.7 | 2.3 | -12.3 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 35.3 | 37.2 | 37.9 | 38.0 | 27.8 | |
Adj. book value per share | Rs | 35.2 | 37.2 | 37.9 | 38.0 | 27.7 | |
Shares outstanding (eoy) | m | 6.31 | 6.31 | 6.31 | 6.31 | 6.31 | |
Price / Sales ratio | x | 5.4 | 6.5 | 9.1 | 9.6 | 9.7 | |
Avg P/E ratio | x | 90.0 | 85.7 | 194.0 | 690.9 | -5.8 | |
P/CF ratio (eoy) | x | 44.6 | 39.4 | 51.2 | 64.2 | -7.8 | |
Price / Book Value ratio | x | 2.8 | 3.7 | 3.6 | 3.9 | 3.5 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 628 | 868 | 869 | 931 | 610 | |
Total wages/salary | Rs m | 29 | 39 | 25 | 27 | 35 |
VANTA BIOSCIENCE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 117 | 134 | 96 | 97 | 63 | |
Other income | Rs m | 2 | 1 | 0 | 4 | 7 | |
Total revenues | Rs m | 120 | 135 | 96 | 101 | 70 | |
Gross profit | Rs m | 33 | 44 | 39 | 35 | -24 | |
Depreciation | Rs m | 7 | 12 | 13 | 13 | 27 | |
Interest | Rs m | 17 | 19 | 21 | 23 | 59 | |
Profit before tax | Rs m | 11 | 13 | 6 | 2 | -103 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 4 | 3 | 1 | 1 | 2 | |
Profit after tax | Rs m | 7 | 10 | 4 | 1 | -104 | |
Gross profit margin | % | 27.9 | 32.7 | 41.1 | 35.8 | -38.1 | |
Effective tax rate | % | 36.7 | 24.5 | 23.9 | 41.1 | -1.8 | |
Net profit margin | % | 5.9 | 7.6 | 4.7 | 1.4 | -166.4 |
VANTA BIOSCIENCE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 172 | 200 | 200 | 145 | 152 | |
Current liabilities | Rs m | 33 | 100 | 149 | 143 | 177 | |
Net working cap to sales | % | 118.0 | 74.6 | 53.1 | 2.3 | -39.9 | |
Current ratio | x | 5.2 | 2.0 | 1.3 | 1.0 | 0.9 | |
Inventory Days | Days | 72 | 26 | 37 | 87 | 95 | |
Debtors Days | Days | 48,641,630 | 38,000,990 | 76,662,179 | 42,727 | 113,923 | |
Net fixed assets | Rs m | 219 | 287 | 497 | 669 | 695 | |
Share capital | Rs m | 63 | 63 | 63 | 63 | 63 | |
"Free" reserves | Rs m | 159 | 172 | 176 | 177 | 112 | |
Net worth | Rs m | 222 | 235 | 239 | 240 | 175 | |
Long term debt | Rs m | 122 | 137 | 278 | 370 | 471 | |
Total assets | Rs m | 391 | 487 | 697 | 814 | 847 | |
Interest coverage | x | 1.7 | 1.7 | 1.3 | 1.1 | -0.7 | |
Debt to equity ratio | x | 0.5 | 0.6 | 1.2 | 1.5 | 2.7 | |
Sales to assets ratio | x | 0.3 | 0.3 | 0.1 | 0.1 | 0.1 | |
Return on assets | % | 6.1 | 6.1 | 3.7 | 3.0 | -5.4 | |
Return on equity | % | 3.1 | 4.3 | 1.9 | 0.6 | -59.6 | |
Return on capital | % | 8.1 | 8.9 | 5.3 | 4.2 | -6.8 | |
Exports to sales | % | 32.0 | 51.4 | 70.1 | 0 | 34.3 | |
Imports to sales | % | 10.8 | 0.8 | 2.1 | 0 | 0 | |
Exports (fob) | Rs m | 38 | 69 | 67 | 0 | 22 | |
Imports (cif) | Rs m | 13 | 1 | 2 | 0 | 0 | |
Fx inflow | Rs m | 38 | 69 | 67 | 0 | 22 | |
Fx outflow | Rs m | 14 | 3 | 3 | 0 | 0 | |
Net fx | Rs m | 24 | 65 | 65 | 0 | 22 |
VANTA BIOSCIENCE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -10 | 23 | 70 | 53 | -6 | |
From Investments | Rs m | -55 | -74 | -222 | -172 | -59 | |
From Financial Activity | Rs m | 97 | 19 | 177 | 95 | 64 | |
Net Cashflow | Rs m | 32 | -31 | 25 | -24 | -1 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Mohan Krishna Mulakala | COMP SEC: Sangeetha Padam Choudhary | YEAR OF INC: 2016 | BSE CODE: 540729 | FV (Rs): 10 | DIV YIELD (%): - |
More Business Support Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare VANTA BIOSCIENCE With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Asian markets traded higher on Tuesday following overnight gain on Wall Street.